RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • Safety of empagliflozin in patients with type 2 diabetes and chronic kidney disease: Pooled analysis of placebo-controlled clinical trials

Safety of empagliflozin in patients with type 2 diabetes and chronic kidney disease: Pooled analysis of placebo-controlled clinical trials

Add to Collection
RCTs KR Tuttle, A Levin, M Nangaku, T Kadowaki… - Diabetes …, 2022 - Am Diabetes Assoc

Chapter : Section1
Journal Year : 2022
Cited by : 12.0

… A total of 1,522, 722, and 123 patients were classified as having CKD categories G3A (… with CKD category G4 where data are currently limited. Nevertheless, careful consideration of the …..... Read More

Keywords : ["chronic kidney disease pool analysis", "placebocontrolle clinical trial", "type diabetes", "safety", "patient", "empagliflozin"]
PubMed Link : https://diabetesjournals.org/care/article-abstract/45/6/1445/145036
Google Scholar Link : https://scholar.google.com/scholar?cites=2183000590805210624&as_sdt=2005&sciodt=0,5&hl=en&num=20